Jason J. Zoeller, Ph.D.
Affiliations: | 2009 | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Molecular BiologyGoogle:
"Jason Zoeller"Parents
Sign in to add mentor| Renato V. Iozzo | grad student | 2009 | Thomas Jefferson | |
| (Perlecan coordinates developmental angiogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Caswell-Jin JL, McNamara KL, Dering J, et al. (2020) Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial Cancer Research. 80 |
| Zoeller JJ, Vagodny A, Daniels VW, et al. (2020) Abstract P3-11-06: Pre-clinical assessment of combined ABT-263/Navitoclax and ABT-414 or ABBV-321 treatment for EGFR-expressing TNBC Cancer Research. 80 |
| Zoeller JJ, Vagodny A, Taneja K, et al. (2019) Neutralization of BCL-2/XL enhances the cytotoxicity of T-DM1 in vivo. Molecular Cancer Therapeutics |
| Zoeller JJ, Hurvitz SA, Press MF, et al. (2019) Abstract 2978: Clinical evaluation of lapatinib induced BCL-2 adaptive responses Cancer Research. 79: 2978-2978 |
| Rosenbluth JM, Schackmann R, Li C, et al. (2018) Abstract 989: Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages and can form chimeric mammary glands in vivo Cancer Research. 78: 989-989 |
| Neill T, Zoeller J. (2014) Matrix biology highlights. Matrix Biology. 48: 1-2 |
| Zoeller JJ, Bronson RT, Gilmer TM, et al. (2012) Abstract P4-08-05: Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo. Cancer Research. 72: 4834-4834 |
| Schnaar R, Paulson JC, Macauley MS, et al. (2012) Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology Glycobiology. 22: 1518-1650 |
| Brugge J, Muranen T, Zoeller J, et al. (2011) DL1-1: Adaptive Resistance to Targeted Therapies. Cancer Research. 71 |
| San Antonio JD, Zoeller JJ, Habursky K, et al. (2009) A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. The American Journal of Pathology. 175: 1338-47 |